Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study

INTRODUCTION: The majority of stage III patients with non-small cell lung cancer (NSCLC) are unsuitable for concurrent chemoradiotherapy, the non-surgical gold standard of care. As the alternative treatment options of sequential chemoradiotherapy and radiotherapy alone are associated with high local...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslett, Kate, Franks, Kevin, Hanna, Gerard G, Harden, Susan, Hatton, Matthew, Harrow, Stephen, McDonald, Fiona, Ashcroft, Linda, Falk, Sally, Groom, Nicki, Harris, Catherine, McCloskey, Paula, Whitehurst, Philip, Bayman, Neil, Faivre-Finn, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838675/
https://www.ncbi.nlm.nih.gov/pubmed/27084277
http://dx.doi.org/10.1136/bmjopen-2015-010457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838675/
https://www.ncbi.nlm.nih.gov/pubmed/27084277
http://dx.doi.org/10.1136/bmjopen-2015-010457

Ejemplares similares